Emerging technologies for the molecular study of infertility, and potential clinical applications
- PMID: 17908410
- DOI: 10.1016/s1472-6483(10)60372-0
Emerging technologies for the molecular study of infertility, and potential clinical applications
Abstract
The techniques currently used to treat infertility cases are quite limited in their capabilities, due to an incomplete understanding of the molecular activities of germ cells. Fortunately, several technologies are presently being researched that should aid the understanding of the various molecular causes of germ cell pathologies. This review discusses microarray technology, proteomics, metabolic profiling, the PolScope, atomic force microscopy and microfluidics. These technologies have all seen success in preliminary studies, and promise directly or indirectly to improve the low success rates of IVF and other related therapies. However, their widespread use in laboratories and clinics may not be seen until preliminary studies confirming their safety and effectiveness are published, and until standardized protocols for their utilization are established.
Similar articles
-
Microfluidics for sperm analysis and selection.Nat Rev Urol. 2017 Dec;14(12):707-730. doi: 10.1038/nrurol.2017.175. Epub 2017 Oct 31. Nat Rev Urol. 2017. PMID: 29089604 Review.
-
Array-based proteomics: the latest chip challenge.Expert Rev Mol Diagn. 2001 Jul;1(2):145-52. doi: 10.1586/14737159.1.2.145. Expert Rev Mol Diagn. 2001. PMID: 11901809 Review.
-
Microarray-based genomic DNA profiling technologies in clinical molecular diagnostics.Clin Chem. 2009 Apr;55(4):659-69. doi: 10.1373/clinchem.2008.112821. Epub 2009 Feb 20. Clin Chem. 2009. PMID: 19233918 Review.
-
[Recent advances in molecular diagnostic tests].Rinsho Byori. 2002 Nov;Suppl 123:19-29. Rinsho Byori. 2002. PMID: 12652786 Review. Japanese.
-
Applications of microarrays to renal transplantation: progress and possibilities.Front Biosci. 2003 Sep 1;8:s913-23. doi: 10.2741/1175. Front Biosci. 2003. PMID: 12957854 Review.
Cited by
-
Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011872. doi: 10.1002/14651858.CD011872.pub3. Cochrane Database Syst Rev. 2018. PMID: 29547689 Free PMC article.
-
MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration.Reprod Biol Endocrinol. 2011 Mar 6;9:29. doi: 10.1186/1477-7827-9-29. Reprod Biol Endocrinol. 2011. PMID: 21375772 Free PMC article.
-
Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011872. doi: 10.1002/14651858.CD011872.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Mar 16;3:CD011872. doi: 10.1002/14651858.CD011872.pub3. PMID: 28534597 Free PMC article. Updated.
-
OMICS: Current and future perspectives in reproductive medicine and technology.J Hum Reprod Sci. 2014 Apr;7(2):73-92. doi: 10.4103/0974-1208.138857. J Hum Reprod Sci. 2014. PMID: 25191020 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical